Effect of Thera-Band Elastic Band-Assisted Progressive Resistance Training on Physical Health in Diabetes Patients with Frailty Syndrome
1 other identifier
interventional
96
1 country
1
Brief Summary
Goal: The goal of this clinical trial is to evaluate the effectiveness of Thera-Band elastic band-assisted progressive resistance training (PRT) in improving physical health and reducing frailty in older adults with diabetes mellitus (DM) complicated by frailty syndrome (FS). Main Questions: Does Thera-Band elastic band-assisted PRT lower blood glucose levels in patients with DM? Does Thera-Band elastic band-assisted PRT improve physical function, as measured by handgrip strength and gait speed, in patients with FS? If there is a comparison group: Researchers will compare the Thera-Band elastic band PRT group to the conventional treatment group to see if the PRT intervention leads to greater improvements in physical health and frailty status. Participants will: Undergo Thera-Band elastic band-assisted progressive resistance training for 12 weeks, attending sessions three times a week. Complete assessments of their blood glucose levels and physical function before and after the intervention. Provide feedback on their fatigue, psychological state, and any adverse reactions during the training period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
October 21, 2024
CompletedFirst Posted
Study publicly available on registry
October 26, 2024
CompletedOctober 26, 2024
October 1, 2024
11 months
October 21, 2024
October 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Handgrip Strength
Measured using an electronic hand muscle developer to assess muscle strength and physical function at baseline and after the 12-week intervention period.
From enrollment to the end of treatment at 12 weeks.
Usual Gait Speed
Assessed using the 6-minute walk test to evaluate mobility and physical performance before and after the intervention.
From enrollment to the end of treatment at 12 weeks.
Secondary Outcomes (8)
Short Physical Performance Battery
From enrollment to the end of treatment at 12 weeks.
Fasting Blood Glucose
From enrollment to the end of treatment at 12 weeks.
2-Hour Postprandial Blood Glucose
From enrollment to the end of treatment at 12 weeks.
Glycosylated Hemoglobin (HbA1c)
From enrollment to the end of treatment at 12 weeks.
FRAIL Scale
From enrollment to the end of treatment at 12 weeks.
- +3 more secondary outcomes
Study Arms (2)
Thera-Band Elastic Band-Assisted Progressive Resistance Training Group
EXPERIMENTALIn the Thera-Band Elastic Band-Assisted Progressive Resistance Training Group, participants will engage in a structured exercise program utilizing Thera-Band elastic bands for resistance training. The intervention will occur three times a week for 12 weeks, with each session lasting approximately 50 minutes. Exercises will target major muscle groups, including upper and lower limbs, and will be designed to improve strength, balance, and overall physical function. Participants will be instructed to exercise at 60%-80% of their maximum heart rate to ensure an effective training intensity. The program aims to enhance physical health, reduce frailty, and improve quality of life for older adults with diabetes mellitus and frailty syndrome. Participants will receive guidance from trained exercise instructors and will be monitored for any adverse reactions during the training sessions.
Conventional Diabetes Management Group
ACTIVE COMPARATORIn the Conventional Diabetes Management Group, participants will receive standard care for diabetes management, which includes basic health education and guidance on diet, exercise, medication adherence, and daily care practices. This group will not engage in the Thera-Band exercise program but will continue their usual activities and follow-up care as prescribed by their healthcare providers. The aim of this arm is to provide a comparison to the experimental group regarding the effectiveness of the elastic band-assisted progressive resistance training on physical health and frailty outcomes. Participants will be monitored for their blood glucose levels and overall health status throughout the study period, and any changes in their condition will be documented.
Interventions
Thera-Band Elastic Band-Assisted Progressive Resistance Training: This intervention involves a structured exercise program using Thera-Band elastic bands for resistance training, conducted three times a week for 12 weeks. Each session lasts approximately 50 minutes and includes exercises targeting major muscle groups, such as upper arms, shoulders, chest, lumbar, and lower limbs. Participants will perform each exercise for 8-12 repetitions in 2-3 sets with 1-minute intervals, aiming for an intensity of 60%-80% of their maximum heart rate. The program is designed to improve strength, balance, and overall physical function, thereby reducing frailty in older adults with diabetes.
Conventional Diabetes Management: Participants in this arm will receive standard care for diabetes management, which includes health education covering diet, medication adherence, exercise recommendations, and routine health monitoring. This arm serves as a comparator to assess the effectiveness of the progressive resistance training intervention.
Eligibility Criteria
You may qualify if:
- Diagnosed with Type 2 Diabetes Mellitus (T2DM).
- Fasting blood glucose level of less than 16.7 mmol/L.
- Frailty score of 4 points or higher on the Tilburg Frailty Indicator (TFI).
- Aged 60 years or older.
- Muscle strength rated at level 4 or higher.
- No participation in regular exercise in the past.
You may not qualify if:
- Presence of serious heart conditions, such as severe heart failure or significant heart disease.
- Loss of consciousness (e.g., being excessively sleepy or in a coma).
- Diagnosis of severe Alzheimer's disease or other significant cognitive impairments.
- Physical disabilities that would prevent participation in exercise.
- Diagnosis of severe osteoporosis (weak bones).
- Communication barriers that prevent understanding or cooperation with the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ZhejiangRongjun
Jiaxing, Zhejiang, China
Related Publications (1)
Ye M, Zhu Q, Yang H, Zhang L, Cai X. Effect of thera-band resistance training on diabetic patients with frailty syndrome. BMC Sports Sci Med Rehabil. 2025 Sep 29;17(1):284. doi: 10.1186/s13102-025-01350-9.
PMID: 41024136DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- In this clinical trial, there will be no masking of participants, care providers, investigators, or outcomes assessors. All parties involved will be aware of the interventions assigned to participants. This decision was made to facilitate adherence to the Thera-Band elastic band-assisted progressive resistance training program and to ensure that the research team can monitor the participants effectively throughout the intervention. While this approach allows for clear communication and immediate feedback regarding the exercise protocol, it may introduce bias in the assessment of outcomes. However, objective measures such as blood glucose levels and physical performance assessments will be used to minimize this potential bias.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2024
First Posted
October 26, 2024
Study Start
April 1, 2023
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
October 26, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Individual participant data (IPD) and supporting information will be made available starting 6 months after the publication of the primary study results. This time frame allows for the completion of data analysis and publication processes. The data will remain accessible for a period of 5 years following the publication date to facilitate ongoing research and collaboration. During this time, interested researchers can request access to the IPD and any accompanying supporting information, subject to a data sharing agreement and ethical review to ensure participant confidentiality and proper use of the data.
- Access Criteria
- Access to individual participant data (IPD) and supporting information will be granted to qualified researchers and institutions for legitimate scientific research purposes, such as further analyses that build on the original study findings. Requests for access must be submitted in writing and will be reviewed by an independent Data Access Committee (DAC) comprised of study investigators and ethical experts. The DAC will evaluate requests based on criteria including the scientific merit of the proposed analysis, adherence to ethical standards, and feasibility of data sharing. Approved researchers will be required to sign a data sharing agreement that outlines the terms of use, including ensuring participant confidentiality and data protection measures. Access will be facilitated through a secure online platform where data can be accessed in compliance with relevant regulations and guidelines.
There is a plan to share individual participant data (IPD) collected in this study, specifically including all relevant data sets that underpin the published results. This will encompass demographic information, clinical assessments, treatment responses, and outcome measures related to blood glucose levels, handgrip strength, gait speed, and psychological evaluations. The data will be de-identified to ensure participant confidentiality and will be made available to qualified researchers upon request after the study's completion. Sharing these data aims to promote transparency, facilitate further research, and enhance the understanding of the effects of Thera-Band elastic band-assisted progressive resistance-exercise training on patients with diabetes mellitus and frailty syndrome. Access will be subject to ethical review and data sharing agreements to protect participant privacy.